These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 37213403)

  • 1. Fecal microbiota transplantation for the maintenance of remission in patients with ulcerative colitis: A randomized controlled trial.
    Lahtinen P; Jalanka J; Mattila E; Tillonen J; Bergman P; Satokari R; Arkkila P
    World J Gastroenterol; 2023 May; 29(17):2666-2678. PubMed ID: 37213403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal transplantation for treatment of inflammatory bowel disease.
    Imdad A; Nicholson MR; Tanner-Smith EE; Zackular JP; Gomez-Duarte OG; Beaulieu DB; Acra S
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012774. PubMed ID: 30480772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis: A Randomized Clinical Trial.
    Costello SP; Hughes PA; Waters O; Bryant RV; Vincent AD; Blatchford P; Katsikeros R; Makanyanga J; Campaniello MA; Mavrangelos C; Rosewarne CP; Bickley C; Peters C; Schoeman MN; Conlon MA; Roberts-Thomson IC; Andrews JM
    JAMA; 2019 Jan; 321(2):156-164. PubMed ID: 30644982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidonor FMT capsules improve symptoms and decrease fecal calprotectin in ulcerative colitis patients while treated - an open-label pilot study.
    Cold F; Browne PD; Günther S; Halkjaer SI; Petersen AM; Al-Gibouri Z; Hansen LH; Christensen AH
    Scand J Gastroenterol; 2019 Mar; 54(3):289-296. PubMed ID: 30946615
    [No Abstract]   [Full Text] [Related]  

  • 5. Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial.
    Haifer C; Paramsothy S; Kaakoush NO; Saikal A; Ghaly S; Yang T; Luu LDW; Borody TJ; Leong RW
    Lancet Gastroenterol Hepatol; 2022 Feb; 7(2):141-151. PubMed ID: 34863330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Fecal Microbiota Transplantation in the Treatment of Active Ulcerative Colitis: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials.
    El Hage Chehade N; Ghoneim S; Shah S; Chahine A; Mourad FH; Francis FF; Binion DG; Farraye FA; Hashash JG
    Inflamm Bowel Dis; 2023 May; 29(5):808-817. PubMed ID: 35766805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis.
    Paramsothy S; Nielsen S; Kamm MA; Deshpande NP; Faith JJ; Clemente JC; Paramsothy R; Walsh AJ; van den Bogaerde J; Samuel D; Leong RWL; Connor S; Ng W; Lin E; Borody TJ; Wilkins MR; Colombel JF; Mitchell HM; Kaakoush NO
    Gastroenterology; 2019 Apr; 156(5):1440-1454.e2. PubMed ID: 30529583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial.
    Moayyedi P; Surette MG; Kim PT; Libertucci J; Wolfe M; Onischi C; Armstrong D; Marshall JK; Kassam Z; Reinisch W; Lee CH
    Gastroenterology; 2015 Jul; 149(1):102-109.e6. PubMed ID: 25857665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term efficacy and safety of monotherapy with a single fresh fecal microbiota transplant for recurrent active ulcerative colitis: a prospective randomized pilot study.
    Fang H; Fu L; Li X; Lu C; Su Y; Xiong K; Zhang L
    Microb Cell Fact; 2021 Jan; 20(1):18. PubMed ID: 33468164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of single fecal microbiota transplantation for Japanese patients with mild to moderately active ulcerative colitis.
    Nishida A; Imaeda H; Ohno M; Inatomi O; Bamba S; Sugimoto M; Andoh A
    J Gastroenterol; 2017 Apr; 52(4):476-482. PubMed ID: 27730312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Faecal Microbiota Transplantation for Maintenance of Remission in Patients With Ulcerative Colitis: A Pilot Study.
    Sood A; Mahajan R; Singh A; Midha V; Mehta V; Narang V; Singh T; Singh Pannu A
    J Crohns Colitis; 2019 Sep; 13(10):1311-1317. PubMed ID: 30873549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis.
    Rossen NG; Fuentes S; van der Spek MJ; Tijssen JG; Hartman JH; Duflou A; Löwenberg M; van den Brink GR; Mathus-Vliegen EM; de Vos WM; Zoetendal EG; D'Haens GR; Ponsioen CY
    Gastroenterology; 2015 Jul; 149(1):110-118.e4. PubMed ID: 25836986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early fecal microbiome transfer after donor defecation determines response in patients with moderate to severe ulcerative colitis.
    Singh A; Mahajan R; Kahlon BK; Dhaliwal AS; Midha V; Mehta V; Bansal N; Singh D; Sood A
    Indian J Gastroenterol; 2022 Aug; 41(4):389-396. PubMed ID: 36121613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of fecal microbiota transplantation
    Tkach S; Dorofeyev A; Kuzenko I; Falalyeyeva T; Tsyryuk O; Kovalchuk O; Kobyliak N; Abenavoli L; Boccuto L
    Front Med (Lausanne); 2022; 9():1049849. PubMed ID: 36714101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis.
    Urushikubo J; Yanai S; Nakamura S; Kawasaki K; Akasaka R; Sato K; Toya Y; Asakura K; Gonai T; Sugai T; Matsumoto T
    World J Gastroenterol; 2018 Oct; 24(38):4384-4392. PubMed ID: 30344422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific fungi associated with response to capsulized fecal microbiota transplantation in patients with active ulcerative colitis.
    Chen Q; Fan Y; Zhang B; Yan C; Chen Z; Wang L; Hu Y; Huang Q; Su J; Ren J; Xu H
    Front Cell Infect Microbiol; 2022; 12():1086885. PubMed ID: 36683707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal microbiota transplantation versus glucocorticoids for the induction of remission in mild to moderate ulcerative colitis.
    Huang C; Huang Z; Ding L; Fu Y; Fan J; Mei Q; Lou L; Wang J; Yin N; Lu Y; Guo S; Zeng Y
    J Transl Med; 2022 Aug; 20(1):354. PubMed ID: 35962454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capsulized Fecal Microbiota Transplantation Induces Remission in Patients with Ulcerative Colitis by Gut Microbial Colonization and Metabolite Regulation.
    Chen Q; Fan Y; Zhang B; Yan C; Zhang Q; Ke Y; Chen Z; Wang L; Shi H; Hu Y; Huang Q; Su J; Xie C; Zhang X; Zhou L; Ren J; Xu H
    Microbiol Spectr; 2023 Jun; 11(3):e0415222. PubMed ID: 37093057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daily, oral FMT for long-term maintenance therapy in ulcerative colitis: results of a single-center, prospective, randomized pilot study.
    Crothers JW; Chu ND; Nguyen LTT; Phillips M; Collins C; Fortner K; Del Rio-Guerra R; Lavoie B; Callas P; Velez M; Cohn A; Elliott RJ; Wong WF; Vo E; Wilcox R; Smith M; Kassam Z; Budd R; Alm EJ; Mawe GM; Moses PL
    BMC Gastroenterol; 2021 Jul; 21(1):281. PubMed ID: 34238227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protocol for faecal microbiota transplantation in ulcerative colitis (FMTUC): a randomised feasibility study.
    Jitsumura M; Cunningham AL; Hitchings MD; Islam S; Davies AP; Row PE; Riddell AD; Kinross J; Wilkinson TS; Jenkins GJ; Williams JG; Harris DA
    BMJ Open; 2018 Oct; 8(10):e021987. PubMed ID: 30341117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.